3rd Biophysics for Drug Discovery Summit 2026

AI is transforming every corner of drug discovery, and biophysics is no exception. From predicting molecular interactions to streamlining data analysis with machine learning, AI is enabling faster, more informed early-stage decisions. Meanwhile, experimental biophysics continues to evolve, with high-resolution and high-throughput platforms expanding the boundaries of what can be measured. Techniques like focal molography, alongside innovations in membrane mimetics and nanodiscs, are providing unprecedented insight into complex targets, including previously intractable membrane proteins.

As targets grow more complex and modalities more diverse, the demand for accurate biophysical understanding has never been more essential. From prioritizing hits and defining on-target engagement to optimizing leads and informing CMC and formulation, biophysics underpins confident, data-driven decisions across the discovery pipeline.

The 3rd Biophysics for Drug Discovery Summit offers a rare, highly technical, industry-focused forum dedicated solely to biophysics. Unlike broader drug discovery meetings, this summit provides a comprehensive view of techniques, emerging technologies, and practical applications. Through case studies, panel discussions, and interactive dialogue, attendees will explore how next-generation biophysics drives predictive pipelines and accelerates discovery.

URLs:
Website: https://go.evvnt.com/3437272-0?pid=185
Tickets: https://go.evvnt.com/3437272-2?pid=185
Brochure: https://go.evvnt.com/3437272-3?pid=185

Date and Time: On Tue, 28 Apr 2026 08:30 - Thu, 30 Apr 2026 15:15

Venue Details: Wyndham Boston Beacon Hill, 5 Blossom Street, Boston, Massachusetts, 02114, United States

Category: Conferences | Science, Health and Medicine | Pharmaceuticals | Drug Discovery

Prices:
Drug Developer Pricing - 3 Day Pass (Conference + Workshop Day): USD 3697.00,
Drug Developer Pricing - 2 Day Pass (Conference Only): USD 2699.00,
Academic Pricing - 3 Day Pass (Conference + Workshop Day): USD 3047.00,
Academic Pricing - 2 Day Pass (Conference Only): USD 2999.00,
Solution Provider Pricing - 3 Day Pass (Conference + Workshop Day): USD 5297.00,
Solution Provider Pricing - 2 Day Pass (Conference Only): USD 3799.00

Speakers: Pooja Sharma, Principal Scientist, Amgen Inc., Hua Xu, Director, Head of Chemical Biology and Proteomics, AstraZeneca, Ivan Budyak, Senior Director, Analytical Development Biophysical Characterization, Eli Lilly and Company, Soo Ro, Principal Scientist, Biophysics Group, Genentech, Florian Horenkamp, Biophysics Lab Head, Senior Principal Scientist, Pfizer, David Ban, Associate Director, Regeneron, Sylwia Huber, Senior Principal Scientist and Biophysics Matrix Lead, Roche, Alexey Rak, Head of Biostructure and Biophysics, Scientific Fellow, Sanofi, James Bowman, Chief Technology Officer, AI Proteins, Roman Agafonov, Associate Director, C4 Therapeutics Inc, Kan Zhu, Director, Head of Analytical Biochemistry, CSL Seqirus, Jay Duffner, Associate Director - Discovery Biology, Frontier Medicines, Monica Menzenski, Director, Generate Biomedicines, Michael LeVine, Vice President, Modeling and Simulation, Genesis Therapeutics, Modi Sathappa, Principal Scientist, Kymera Therapeutics, Kara Herlihy, Senior Director, Biomolecular Sciences, Magnet Biomedicine, Jonathan, Hopper Vice President and Founder- Platforms, OMass Therapeutics, Bryan Dunyak, Director, Biomolecular Sciences and Lead Discovery, Remix Therapeutics, Kejia Wu, Post Doc, Baker Lab, Institute for Protein Design, Washington University School of Medicine in St. Louis